Is PVLA or QTTB more undervalued in 2026?

CirclFi compares Palvella Therapeutics, Inc. (PVLA) and Q32 Bio Inc. (QTTB) using 13 institutional-grade valuation models. PVLA has a Quality of Company score of 5.1/10 while QTTB scores 7.5/10.

Which is a better buy — PVLA or QTTB?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do PVLA and QTTB valuations compare?

PVLA at $118.46 and QTTB at $11.05 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

PVLA vs QTTB Valuation Comparison 2026 — Intrinsic Value Analysis

PVLA

Pharmaceutical Preparations

Palvella Therapeutics, Inc.

Quality

5.1

out of 10

Value Trap

SAFE

Price

$118.46

Last close

Models

9/13

Active

QTTB

Pharmaceutical Preparations

Q32 Bio Inc.

Quality

7.5

out of 10

Value Trap

SAFE

Price

$11.05

Last close

Models

12/13

Active

Model-by-Model Comparison

Model	Type	PVLA Fair Value	PVLA Upside	QTTB Fair Value	QTTB Upside
Bayesian DCF	Intrinsic	$39.07	-67.0%	$11.10	+0.5%
Earnings Power Value	Intrinsic	$5.19	-95.9%	$9.81	-11.2%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for PVLA vs QTTB — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

PVLA vs QTTB — Which Stock Is More Undervalued?

QTTB scores higher with a 7.5/10 quality rating vs PVLA's 5.1/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Palvella Therapeutics, Inc. (PVLA) and Q32 Bio Inc. (QTTB) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

PVLA currently trades at $118.46 with a QOC of 5.1/10, while QTTB trades at $11.05 with a QOC of 7.5/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).